Nanoparticles-Based Oligonucleotides Delivery in Cancer: Role of Zebrafish as Animal Model
Oligonucleotide (ON) therapeutics are molecular target agents composed of chemically synthesized DNA or RNA molecules capable of inhibiting gene expression or protein function. How ON therapeutics can efficiently reach the inside of target cells remains a problem still to be solved in the majority o...
Main Authors: | Sara Bozzer, Michele Dal Bo, Giuseppe Toffoli, Paolo Macor, Sara Capolla |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/8/1106 |
Similar Items
-
Delivery of therapeutic oligonucleotides in nanoscale
by: Lei Wu, et al.
Published: (2022-01-01) -
Delivery of Oligonucleotides Using a Self-Degradable Lipid-Like Material
by: Hiroki Tanaka, et al.
Published: (2021-04-01) -
Delivery of antisense oligonucleotide using polyethylenimine-based lipid nanoparticle modified with cell penetrating peptide
by: Shuang Yang, et al.
Published: (2019-01-01) -
Transport Oligonucleotides–a Novel System for Intracellular Delivery Of Antisense Therapeutics
by: Oleg V. Markov, et al.
Published: (2020-08-01) -
The role of chorion on toxicity of silver nanoparticles in the embryonic zebrafish assay
by: Ki-Tae Kim, et al.
Published: (2014-12-01)